[Association of CHRNA4 Gene Polymorphisms with Response to Antidepressant among Ethnic Han Chinese].

Jianying Yu,Zaiquan Dong,Tao Yu,Xirong Li,Xueli Sun
DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2019.12.020
2019-01-01
Abstract:OBJECTIVE:To assess the association of single nucleotide polymorphisms (SNPs) CHRNA4 gene with response to selective serotonin re-uptake inhibitors (SSRIs) for the treatment of major depressive disorder (MDD).METHODS:For 304 patients receiving drug treatment for major depression, 2 SNPs, namely rs4522666 and rs4603829, of the CHRNA4 gene were determined by matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry. HAMD-17 was adopted as the primary rating tool to evaluate the severity of depression on the baseline and at the end of 1st, 2nd, 4th and 6th weeks treatment.RESULTS:The frequency of GG genotype/G allele for rs4522666 differed significantly from that of TT and GT genotypes/T allele between responders and non-responders (P=0.015 and P=0.006, respectively). No significant difference was found in genotypic and allelic frequencies of rs4603829 between the two groups (P> 0.05).CONCLUSION:SNPs of the CHRNA4 gene may play an important role in the response to antidepressant drugs among ethnic Han Chinese with MDD.
What problem does this paper attempt to address?